Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell lymphoma-associated long non-coding RNA 1 (TCLlnc1), also known as ferritin heavy chain 1 pseudogene 24 (FTH1P24), is a long non-coding RNA identified as overexpressed in peripheral T cell lymphoma (PTCL)[2][4][1]. TCLlnc1 acts as a modular scaffold, directly interacting with HNRNPD and YBX1 proteins to upregulate TGFB2 and TGFBR1 gene transcription, thereby activating the TGF-β signaling pathway and promoting lymphoma cell proliferation and migration[2][4]. High serum levels correlate with poor prognosis in PTCL patients, supporting its potential as a biomarker and therapeutic target[2][4]. This gene is a non-protein-coding pseudogene, distinct from the active ferritin heavy chain (FTH1)[1]. No direct drug interactions or established safety concerns have been documented for this lncRNA.
Functions as a modular scaffold for protein complexes (HNRNPD and YBX1); Upregulation of transcription of TGFB2 and TGFBR1 genes; Activation of TGF-β signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell lymphoma-associated long non-coding RNA 1 (TCLlnc1).